NCT05185258View on ClinicalTrials.gov

Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 16, 2022

Primary Completion Date

January 15, 2024

Study Completion Date

July 15, 2026

Conditions
Psoriasis VulgarisPsoriasisSkin DiseasesSkin Diseases, PapulosquamousSkin and Connective Tissue Diseases
Interventions
DRUG

Enstilar

Topical foam

DRUG

Placebo-vehicle

Topical foam

Trial Locations (1)

8200

Department of Dermatology, Aarhus N

All Listed Sponsors
lead

Aarhus University Hospital

OTHER